Historique
Rapport
WHO expert committee on drug dependence. 47th report
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
Forty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) (14-18 October 2024; WHO headquarters, Geneva, Switzerland)
Année
2025
Page(s) :
198 p.
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Rapports techniques / Technical report series, 1065
ISBN :
978-92-4-010764-9
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
RECOMMANDATION
;
CONTROLE DES STUPEFIANTS
;
DROIT INTERNATIONAL
;
CANNABIS
;
DROGUES DE SYNTHESE
;
CANNABINOIDES
;
CHIMIE
;
POTENTIEL ADDICTIF
;
FABRICATION
;
PHARMACOLOGIE
;
USAGE THERAPEUTIQUE
;
TOXICOLOGIE
;
OPIOIDES
;
CATHINONES
;
NITAZENES
Résumé :
The Forty-seventh Meeting of the World Health Organization (WHO)'s Expert Committee on Drug Dependence (ECDD) was convened from 14 to 18 October 2024 and was coordinated from the WHO headquarters in Geneva.
The Forty-seventh WHO ECDD critically reviewed seven new psychoactive substances, comprising one synthetic cannabinoid (hexahydrocannabinol), four novel synthetic opioids (protonitazepyne, metonitazepyne, etonitazepipne, N-desethyl isotonitazene), one dissociative-type substance (3-hydroxyphencyclidine) and one cathinone/stimulant (N-ethylheptedrone). It also reviewed the medicine carisoprodol.
A critical review was undertaken of data on the use of each substance and its effects, so that the Expert Committee could determine whether the information available on these substances justified scheduling in the 1961 or 1971 Convention. This report summarizes the findings of the Forty-seventh ECDD meeting. [Editor's abstract]
The Forty-seventh WHO ECDD critically reviewed seven new psychoactive substances, comprising one synthetic cannabinoid (hexahydrocannabinol), four novel synthetic opioids (protonitazepyne, metonitazepyne, etonitazepipne, N-desethyl isotonitazene), one dissociative-type substance (3-hydroxyphencyclidine) and one cathinone/stimulant (N-ethylheptedrone). It also reviewed the medicine carisoprodol.
A critical review was undertaken of data on the use of each substance and its effects, so that the Expert Committee could determine whether the information available on these substances justified scheduling in the 1961 or 1971 Convention. This report summarizes the findings of the Forty-seventh ECDD meeting. [Editor's abstract]